Blue Dye 2 vs Azodicarbonamide: which is worse?

What is Blue Dye 2?

Blue Dye 2 (Indigotine/Indigo Carmine) is a synthetic disulfonated derivative of indigo. Unlike natural indigo from the indigo plant, the FD&C version is synthetically manufactured from petroleum. It produces a dark royal blue to indigo color and is used in food, pharmaceuticals, and medical diagnostics.

What is Azodicarbonamide?

Azodicarbonamide (ADA) is a synthetic chemical used in the food industry as a flour bleaching agent and dough conditioner, and industrially as a blowing agent in foam rubber and plastic production. Its chemical formula is C2H4N4O2. When it reacts with water or heat, it breaks down into biurea (primary product) and semicarbazide (SEM).

Documented risks

Blue Dye 2: Animal studies conducted in the 1980s found that high-dose Blue Dye 2 caused brain tumors in male rats. An NTP bioassay (1987) found statistically significant increases in brain gliomas (astrocytomas) in male rats given high doses. The FDA reviewed these findings and determined that the doses far exceeded typical human dietary exposure. Nonetheless, the tumor finding remains in the scientific record as a concerning data point. EFSA's 2010 safety evaluation of Indigo Carmine (E132) reached an unusual conclusion: it could not establish an ADI due to data limitations, including the brain tumor findings. This means EFSA adopted an implicit conservative position — it neither declared Blue 2 safe nor formally banned it, but the absence of an established ADI signals scientific uncertainty. In medical diagnostic use, high intravenous doses of Indigo Carmine can cause hypertension, bradycardia, and in rare cases anaphylaxis. These are dose-specific clinical pharmacological effects, not relevant to dietary consumption at food use levels. Blue 2 was not included in the 2007 Lancet hyperactivity study. Limited direct research links Blue 2 to behavioral effects. The FDA's April 2025 announcement includes Blue 2 in the class of petroleum-based synthetic dyes to be phased out of the US food supply, reflecting updated policy on the category rather than specific new Blue 2 toxicity data.

Azodicarbonamide: ADA's primary food safety concern is its breakdown to semicarbazide (SEM) during baking. In a 2002 study, SEM was found to increase the incidence of vascular tumors in female mice at high doses. This single animal finding was sufficient under the EU's precautionary principle to ban ADA in food use in 2005. The FDA conducted a comprehensive SEM exposure assessment in 2016, concluding that US population exposure to SEM from ADA-treated bread is many orders of magnitude below doses showing tumor effects in rodents and does not warrant regulatory change. This reflects the FDA's risk-based approach. Urethane (ethyl carbamate) is another potentially harmful breakdown product of ADA. Urethane is classified as an IARC Group 2A probable human carcinogen. Small amounts of urethane can form from SEM in fermented or alcohol-containing environments. The 2014 'yoga mat chemical' controversy highlighted ADA's dual use: it is the same chemical used as a blowing agent in foam rubber and plastic manufacturing — including yoga mats. Consumer advocacy blogger Vani Hari's 'Food Babe' campaign led over 50,000 people to petition Subway, which voluntarily removed ADA from its bread in 2014. The dual industrial-food use raised public concern even though ADA's behavior in each context is chemically different. From occupational health: workers exposed to ADA powder in bakery or plastic manufacturing settings can develop occupational asthma. WHO recognizes ADA as a respiratory sensitizer in occupational settings, though dietary exposure through bread is fundamentally different from inhalation exposure.